Arboretum Ventures, an Ann Arbor, MI, VC firm that invests in early-stage companies, today announced (PDF) completion of Series A preferred stock financing with Life Magnetics, a University of Michigan spinout developing a desktop in vitro diagnostic device and disposable cartridge assay for rapidly testing bacterial infections. The investment amount was not announced. The device being developed will rapidly determine bacterial response to antibiotics within 8 hours of sample collection, according to the company, which builds on technology licensed from U-M.
Author: Howard Lovy
Howard Lovy is a veteran journalist who has focused primarily on technology, science and innovation during the past decade.
In 2001, he helped launch Small Times Magazine, a nanotech publication based in Ann Arbor, MI, where he built the freelance team and worked closely with writers to set the tone and style for an emerging sector that had never before been covered from a business perspective. Lovy's work at Small Times, and on one of the first nanotechnology-themed blogs, helped him earn a reputation for making complex subjects understandable, interesting, and even entertaining for a broad audience. It also earned him the 2004 Prize in Communication from the Foresight Institute, a nanotech think tank.
In his freelance work, Lovy covers nanotechnology in addition to technological innovation in Michigan with an emphasis on efforts to survive and retool in the state's post-automotive age. Lovy's work has appeared in many publications, including Wired News, Salon.com, the Wall Street Journal, The Detroit News, The Scientist, the Forbes/Wolfe Nanotech Report, Michigan Messenger, and the Ann Arbor Chronicle.
View all posts by Howard Lovy